DEFINITIVE PROXY STATEMENT

Company

Tonix Pharmaceuticals Holding Corp.

Filed

December 13, 2019

Period of Report

January 16, 2020

Accession Number

0001387131-19-009537

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →